Introduction
The human endometrium is a dynamic tissue that undergoes differentiation, regeneration, cellular proliferation, and breakdown at each menstrual cycle during women's reproductive years (Figueira et al., 2011) . It has the ability to grow from 0.5-1 mm in thickness at the initial stage to 5-7 mm in thickness after each menstrual cycle. In addition, endometrial regeneration occurs in postmenopausal women on estrogen replacement therapy (Ulrich et al., 2014) . Likewise, hemopoietic tissue, the epidermis, and the intestinal epithelium have a similar regeneration capacity (Pittenger et al., 2009) .
Adult stem cells are stem cells found in the majority of organs and tissues in adult organisms and they are known to function in long-term tissue maintenance and repair due to their ability to differentiate into a number of different cell types found in their tissue of residence (Romanov et al., 2005; Pittenger et al., 2009) . According to the studies conducted by Gargett et al. (2006 Gargett et al. ( , 2009 , the regenerative capacity of the human endometrium is driven by the endometrial stem/progenitor cells that reside in the basal layer of the human endometrium, which are responsible for the monthly stromal and vascular regeneration. Human endometrial stem cells (hESCs) show progenitor celllike properties including differentiation and proliferation capacity and carry enormous potential for estrogenic, myogenic, adipogenic, and chondrogenic differentiation (Gargett et al., 2010; Ai et al., 2012; Miyazaki et al., 2012) . Studies about hESC markers show that endometrial stem cells showed a similar CD marker profile to the bone marrow-derived mesenchymal stem cells (Wang et al., 2012) . Subsequent research identified CD146 and PDGF-Rβ as two specific endometrial stem cell markers in addition to CD90, CD73, CD105, CD31, CD44, CD29, CD14, and integrin beta 1 (Spitzer et al., 2012; Verdi et al., 2014) .
The first study about the isolation of stem cells from the human endometrium used enzymatic digestion of endometrium biopsy samples with trypsin (Gargett et al., 2006) . On the other hand, another study showed that collagenase type 1 digestion used for the isolation of mesenchymal stem cells from the human endometrium yielded higher total cell number than other methods such as hyaluronidase digestion (Verdi et al., 2014) . A recent study showed that isolation of hESCs using trypsin led to higher efficiency when compared to the nonenzymatic isolation of these cells from endometrial biopsy (Figueira et al., 2011) . However, there is no study that compares the isolation efficiencies of hESCs from human endometrium biopsy samples by using collagenase type 1, trypsin, and scalpel mincing. Therefore, in our current study, we compared the efficiencies of these two enzymatic isolation methods with nonenzymatic harvest with respect to the hESC yield in the obtained cell populations. In this context, cell populations obtained using three different methods were analyzed for CD90, CD73, CD44, CD105, integrin beta 1, and CD29 (positive) and CD31, CD45, CD34, and CD14 (negative) using a flow cytometer for the early and late passages.
Material and methods

Nonenzymatic isolation of hESCs
The study protocol was approved by the Yeditepe University Research and Ethics Committee. Five different human subjects were involved in the study.
To avoid genetic heterogeneity, endometrium biopsies were taken from same donor and divided into three pieces to be subjected to three different isolation methods. Human endometrial biopsy tissue rinsed in PBS solution (Invitrogen, GIBCO, UK) containing 1% antibiotics was cut with two sterile scalpel blades using a crisscrossing motion until the tissue was finely minced. The sample was resuspended in complete Dulbecco modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine, and 100 U/mL penicillin and 100 µg/mL streptomycin (Invitrogen, GIBCO). Finely minced tissue was placed into a T75 flask (BIOFIL, TCP, Switzerland) and incubated for 2 days to allow cell migration from the tissue onto the tissue culture plastic at 37 °C under humidified conditions and 5% CO 2 /95% air. To remove the minced tissue, the cell monolayer was washed with fresh growth medium and the formation of colonies was observed for 7 days. Five different human subjects were involved in the study. Analysis of CD markers for early and late passages of endometrial stem cells were performed once for each donor, making five experiments in total. Therefore, our results were not affected by genetic heterogeneity between donors. Early passage cells indicate hESCs at passage 3 while late passage cells indicate hESCs at passage 8.
Enzymatic isolation of hESCs by using trypsin
The endometrium biopsy sample was transferred into 10 mL of PBS containing 0.05% trypsin (Invitrogen, GIBCO) and incubated in a shaking water bath at 37 °C with the speed of 50 × g for 1 h. After the digestion step, the cell/ trypsin solution was centrifuged at 400 × g for 5 min and the supernatant was discarded. The pellet was resuspended in complete DMEM and seeded into a tissue culture flask until cells reached confluency of 80%. 2.3. Enzymatic isolation of hESCs by using collagenase type 1 The human endometrium sample was transferred into 10 mL of PBS containing 5 mg/mL collagenase type 1 solution (Invitrogen, GIBCO) and incubated in a shaking water bath at 37 °C with the speed of 50 × g for 1 h. After the incubation step, the tissue suspension was centrifuged at 400 × g for 5 min and the supernatant was discarded. The resulting pellet was resuspended one more time in 0.5% collagenase type 1 solution in PBS and incubated in a shaking water bath at 37 °C with the speed of 50 × g for 90 min. After incubation, cells were spun down at 400 × g for 10 min, and the cell pellet was resuspended in complete DMEM and seeded in a tissue culture flask (Invitrogen, GIBCO) as indicated above.
Culturing and characterization of hESCs
A subculture process was applied when the outgrowth was sufficient (80%-90% confluency). Cells were maintained in complete DMEM up to passage 10 and characterized for the expression of CD cell surface markers at passages 3 (early) and 8 (late) according to the protocol described previously (Tasli et al., 2013) To compare the proliferation index of hESCs isolated by the three different methods, cells were seeded on 96-well plates (2500 cells/well) at the indicated passages and the cell number was determined using the MTS assay at 24, 48, and 72 h in reference to a standard curve as described by the manufacturer's protocol (Sigma-Aldrich, USA).
Results
The comparison of cell proliferation rates among early passage hESCs isolated using the enzymatic trypsin and collagenase type 1 methods and the nonenzymatic method demonstrated that all three types of cell isolation protocols produced cell populations with statistically similar proliferative rates at 24 h ( Figure 1A ). However, when compared to hESCs isolated using trypsin, hESCs that was isolated by the nonenzymatic method (P = 0.03) and collagenase type 1 (P = 0.001) displayed a 1.8-fold increase in the doubling time at the end of 48 h. While no statistically significant difference was detected between hESCs isolated by enzymatic digestion, hESCs obtained using the nonenzymatic method showed 1.5-fold increase in the cell number (P = 0.04) at the end of 48 h. Similarly, when the cell proliferation rates for the late passage cells were analyzed, it was seen that hESCs isolated by the nonenzymatic and trypsin methods exhibited the highest rate of cell proliferation when compared to cells obtained through collagenase type 1 digestion at all time points (P = 0.007; Figure 1B ).
Cell populations obtained using enzymatic isolation with trypsin were analyzed for CD90, CD73, CD44, CD105, integrin beta 1, CD29, CD31, CD45, CD34, and CD14 using the flow cytometer for the early and late passages.
The early passage hESCs prepared by trypsin digestion method were positive for mesenchymal cell surface markers CD 90, CD73, CD44, CD105, integrin beta 1, and CD29 and negative for hematopoietic markers Figure 1 . Analysis of cell proliferation for hESCs isolated using trypsin digestion, the nonenzymatic method, and collagenase type 1 digestion at passage 3 (A) and passage 8 (B). Cells synchronized by serum starvation were seeded into 96-well plates and allowed to attach overnight. MTS assay was performed at 24, 48, and 72 h and cell number was analyzed by correlating absorbance value to the cell number with the help of a standard plate run in parallel with each experiment. CD31, CD45, CD34, and CD14 (Table 1 ). The hESCs expressed 99.74% CD90, 99.97% CD73, 99.83% CD44, 99.89% CD105, 95.33% integrin beta 1, and 99.38% CD29 mesenchymal specific markers and 0.88% CD34, 3.90% CD45, 0.10% CD14, and 0.32% CD31 at the third passage (Figure 2 ). These cells demonstrated the highest level of gated % values for the CD73 and CD105 markers. In the later passage hESCs isolated with trypsin showed a higher expression for the hematopoietic and endothelial marker CD31 (35.59%) and a lower expression for the mesenchymal marker CD44 (17.84%) when compared to their low passage counterparts (Table 2 ). These cells also demonstrated a decrease in the expression percentage of mesenchymal CD markers such as CD90 (62.44%), CD73 (64.72%), and CD105 (60.3%), while that of integrin beta 1 (91.11%) and CD29 (97.50%) remained approximately the same (Figure 3) . hESCs that were isolated by the nonenzymatic method were also characterized for the CD marker immunophenotype at the early and late passages (Table 1 and 2). At the third passage these cells were positive for mesenchyme stemness markers CD90 (97.25%), CD73 (99.25%), CD44 (98.49%), CD105 (99.89%), integrin beta 1 (91.38%), and CD29 (99.99%) and negative for hematopoietic CD antigens CD34 (2.19%), CD45 (2.41%), CD14 (1.67%), and CD31 (1.58%) (Figure 4 ). The isolation of hESCs using the nonenzymatic method showed the highest gated % values for CD29 and CD105 at their third passage. Late passage hESCs obtained by nonenzymatic isolation exhibited similar expression levels of integrin beta 1 (81.49%) and CD29 (99.94%) while a significant decrease of 71%, 68.93%, 53.16%, and 35.53% in CD90, CD73, CD44, and CD105 respectively was detected when compared to early passage hESCs. In addition, hESCs isolated with the nonenzymatic method demonstrated a CD31 high profile at their late passage ( Figure 5 ). Characterization of early passage hESCs isolated by collagenase type 1 demonstrated that these cells expressed 88.74% CD90, 90.55% CD73, 99.27% CD44, 96.92% CD105, 99.92% integrin beta 1, 99.54% CD29, 1.38% CD34, 2.62% CD45, 0.34% CD14, and 1.12% CD31 with the highest gated % value recorded for integrin beta 1 (Figure 6) (Figure 7 ).
Discussion
The therapeutic potential of hESCs has been increasing day by day. Endometrial stem cells can be used for gynecological purposes such as treatment of pelvic floor prolapse, Asherman syndrome, endometriosis, and adenomyosis (Figueira et al., 2011; Nagori et al., 2011; Wolff et al., 2011; Mutlu et al., 2015) . The aim of this current study was the isolation and characterization of mesenchymal stem cells obtained from human endometrium using different isolation protocols including a nonenzymatic procedure and enzymatic digestion with trypsin and collagenase type 1. Adherent cells isolated from human endometrium tissue were characterized by mesenchymal stem cell surface antigens including CD 90, CD73, CD44, CD105, integrin beta 1, and CD29 (positive) and endothelial or hematopoietic markers CD31, CD45, CD34, and CD14 (negative).
The research presented in this article compares the enzymatic and nonenzymatic isolation methods for hESCs not only in terms of the cell efficiencies but also the spontaneous differentiation potential of mesenchymal stem cells to endothelial or hematopoietic lineages through extended passages. Throughout the isolation period, chemicals were not used due to their risk of undesirable effects leading to reprogramming the stem cells (Zhang et al., 2012) .
Recently the human endometrium has been shown as a new mesenchymal stem cell source for reproductive science (Mutlu et al., 2015) . Mesenchymal stem cells from the endometrium retain the ability to differentiate into osteoblasts, chondrocytes myocytes, and adipocytes (Ai et al., 2012) . These headways suggested that hESCs can also be used in the treatment of endometriosis, adenomyosis, and Asherman syndrome and therefore may contribute to the development of new medical strategies to treat infertility (Moore et al., 2008; Mutlu et al., 2015) . Herein, we analyzed the cell yield for three different hESC isolation methods to determine the most suitable protocol to be employed in future studies aiming to use hESCs in regenerative medicine. hESCs were described to display mesenchymal stem cell properties of self-renewal, ability to differentiate, and high proliferative potential in vitro and were characterized to be positive for the mesenchymal stem cell markers but negative for the hematopoietic cell surface markers (Gargett et al., 2009) . In agreement with these findings, the primary cells that we isolated from the endometrium had an adherent phenotype and mesenchymal morphology associated with the expression of mesenchymal stem cell markers and lack of hematopoietic markers.
One of the objectives of this study was to provide suitable growth conditions for hESCs as the in vitro conditions including harvesting and preservation procedures can lead to clonal heterogeneity by inducing differentiation (Chan et al., 2010; Zhang et al., 2012) . Studies demonstrated that hESCs have a tendency to decrease or increase their regeneration efficiency depending on the seeding density and the serum-containing medium is the best choice, ensuring better morphological appearance and improved longevity (Chan et al., 2010; McLeod et al., 2010) . Likewise, the study reported by Patel et al. (2008) demonstrated that a FBSbased medium supported hESC growth with a remarkable proliferation rate. Complete DMEM with 10% FBS was therefore used in the maintenance of hESCs in this study.
The cell yield obtained for nonenzymatic digestion and enzymatic digestion was found to be significantly different in our study as hESCs isolated with the nonenzymatic method displayed a significantly higher duplication time when compared to those obtained through the enzymatic digestion methods at the early passages. Early passage hESCs isolated with three different methods displayed a CD90 , and CD14 -profile with no significant differences in the average expression levels of these markers taken from five independent experiments. When three different cell populations were subjected to serial passage until the eighth passage, only the hESC population isolated with collagenase type 1 retained a profile for positive mesenchymal stem cells and negative endothelial or hematopoietic surface markers while cells harvested with trypsin digestion of the endometrium displayed an increased expression value for the hematopoietic and endothelial marker CD31 with a significant decrease in mesenchymal stem cell surface markers CD90, CD73, CD44, and CD105. In particular, the hESC population isolated with trypsin demonstrated a negative expression profile for CD44 at the eighth passage. The late passage group of hESCs obtained by nonenzymatic harvest not only exhibited a decrease in the expression levels of CD90, CD73, and CD44 mesenchymal stem cell markers (<50%) but also showed positive expression for endothelial marker CD31. Our results therefore suggest that while the use of trypsin, collagenase type 1, and nonenzymatic harvest does not affect the expression of mesenchymal stem cell markers on hESCs' cell surface in the early passages, the long-term maintenance of mesenchymal surface markers could only be achieved in cell isolation with collagenase type 1.
Reproductive medicine and stem cell research are two areas known as nested. Endometrial stem cells can be used for as therapeutics in reproductive sciences (Moore et al., 2008; Mutlu et al., 2015) . Reproductive medicine applications intersect at three main points with stem cell research: fertility preservation, the production of functional gametes from stem cells, and the production of tissues and organs to ensure fertility (Moore et al., 2008) . As future prospects, hESCs may therefore be considered as an easily accessible source of mesenchymal stem cells. While we show differences in the maintenance of mesenchymal stemness in hESCs obtained using enzymatic and nonenzymatic harvest of the endometrium, additional studies will be needed to clarify the differences in the differentiation potential of these cells into different lineages.
